Tower Research Capital LLC (Trc) Neuro Bo Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.4 - $0.9 $5,269 - $11,856	13,174 Added 852.13%	14,720 $7,000
Q1 2022 May 12, 2022	SELL	$0.72 - $1.54 $1,888 - $4,039	-2,623 Reduced 62.92%	1,546 $1,000
Q4 2021 Feb 14, 2022	BUY	$1.22 - $2.5 $4,923 - $10,090	4,036 Added 3034.59%	4,169 $5,000
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.52 $11,081 - $18,346	-4,059 Reduced 96.83%	133 $0
Q2 2021 Aug 16, 2021	SELL	$2.74 - $4.63 $4,893 - $8,269	-1,786 Reduced 29.88%	4,192 $14,000
Q1 2021 May 17, 2021	BUY	$3.93 - $6.68 $16,502 - $28,049	4,199 Added 236.03%	5,978 $26,000
Q4 2020 Feb 16, 2021	SELL	$5.02 - $6.59 $11,380 - $14,939	-2,267 Reduced 56.03%	1,779 $9,000
Q3 2020 Nov 16, 2020	SELL	$5.41 - $8.67 $5,794 - $9,285	-1,071 Reduced 20.93%	4,046 $23,000
Q2 2020 Aug 13, 2020	BUY	$8.05 - $29.44 $38,277 - $139,987	4,755 Added 1313.54%	5,117 $41,000
Q1 2020 May 15, 2020	BUY	$7.24 - $30.0 $2,620 - $10,860	362 New	362 $5,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.